Stephen Bloch

Stephen M.
Bloch was the founder of Radiology Management Systems, Inc., founded in 1995, where the title held was Chief Executive Officer from 1995 to 2002.
Dr. Bloch is the founder of Evolveimmune Therapeutics, Inc., founded in 2019, holding the title of Chief Executive Officer starting in 2019.
Dr. Bloch is the founder of Allyx Therapeutics, Inc., founded in 2020, holding the title of Chief Executive Officer & Director starting in 2020.
Dr. Bloch is also the founder of Tele-Rad, Inc...
Dr. Bloch is Chairman at Liquidia Technologies, Inc. since 2018 and has been with the company since 2009.
Dr. Bloch is Chairman at Liquidia Corp.
since 2020.
Dr. Bloch is Director at DICOM Grid, Inc. Dr. Bloch is Director at Truveris, Inc. Dr. Bloch is Director at Mitraspan, Inc. Dr. Bloch is Director at Corvium, Inc. since 2013.
Dr. Bloch is Director at Envisia Therapeutics, Inc. Dr. Bloch is Director at Onkos Surgical Inc. Dr. Bloch is Director at Genome Medical, Inc. Dr. Bloch is Director at Iantrek, Inc. Dr. Bloch is General Partner at Canaan Management, Inc. since 2002.
Former positions include Chairman at Crossroads Venture Group, Inc., Director at OmniSonics Medical Technologies, Inc., Independent Director at Immedica Pharma US, Inc. from 2005 to 2016, Director at Axial Exchange Inc, and Consultant at Arthur D.
Little, Inc. Education includes a doctorate from Rochester Christian University, undergraduate degree from Dartmouth College, and graduate degree from Harvard University.